Our results showed that the increases in MMP2 and MMP9 mRNA and protein levels in response to HG and CML were reduced to a great extent under conditions of CD147 silencing compared to the siRNA controls (Figure 7A,B). The gene discussed is MMP2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.